Trials / Completed
CompletedNCT00452985
Docetaxel and Carboplatin as First-line Chemotherapy in Early Stage as Well as Advanced or Metastatic Ovarian Cancer
Randomised Study With Docetaxel, Cisplatin and Cyclophosphamide vs Docetaxel and Carboplatin as First Line Chemotherapy With Advanced or Metastatic Ovarian Cancer
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 30 (actual)
- Sponsor
- Sanofi · Industry
- Sex
- Female
- Age
- 15 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
Primary objective: To assess response rate. To record the clinical improvement in relation to stage and histopathological grading. Secondary objective: To determine progression free survival. To find out overall survival. To evaluate the safety of the study regimen.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Docetaxel | 60-75 mg/m² |
| DRUG | Carboplatin | AUC 5 |
Timeline
- Start date
- 2002-02-01
- Primary completion
- 2010-11-01
- Completion
- 2010-11-01
- First posted
- 2007-03-28
- Last updated
- 2012-08-14
Locations
1 site across 1 country: Bangladesh
Source: ClinicalTrials.gov record NCT00452985. Inclusion in this directory is not an endorsement.